FDA Approval to Advance Final FemBloc® Trial with Clear Pathway to Potentially Achieve U.S. FDA Approval – – $12 Million Financing Strengthens Balance Sheet and Extends Cash Runway – ATLANTA, Nov. 14, ...
Vizsla Copper Corp. (TSXV: VCU) (OTCQB: VCUFF) ("Vizsla Copper" or the "Company") is pleased to announce that, due to ...
Q1 2026 Earnings Call Transcript November 13, 2025Research Solutions, Inc. reports earnings inline with expectations.
Q3 2025 Earnings Call November 14, 2025 9:00 AM ESTCompany ParticipantsRicardo Barragan - PresidentRafael Guzmán - Executive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback